
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1011 | 970 | 1031 | 1223 | 1379 | 2268 |
Fund Return | 1.12% | -3% | 3.11% | 6.95% | 6.64% | 8.53% |
Place in category | 49 | 19 | 25 | 22 | 56 | 6 |
% in Category | 29 | 16 | 21 | 8 | 35 | 7 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Delaware Small Cap Core I | 5.36B | -11.48 | 2.70 | 7.09 | ||
Delaware Emerging Markets Instl | 2.85B | 3.39 | 4.53 | 4.81 | ||
Delaware Small Cap Value Instl | 2.31B | -8.70 | 2.70 | 6.49 | ||
Optimum Large Cap Growth Instl | 1.88B | -9.37 | 13.76 | 12.04 | ||
Optimum Large Cap Value Instl | 1.82B | -1.08 | 7.87 | 7.89 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 32.37B | 0.31 | 3.69 | 6.42 | ||
T. Rowe Price Health Sciences | 6.63B | -0.13 | 3.27 | 7.56 | ||
Fidelity Select Health Care | 6.2B | -2.20 | 4.18 | 7.04 | ||
Vanguard Health Care Inv | 5.84B | 0.29 | 3.64 | 6.36 | ||
T. Rowe Price Health Sciences I | 4.76B | -0.06 | 3.40 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.93 | 724.95 | -2.95% | |
UnitedHealth | US91324P1021 | 5.67 | 302.98 | -5.78% | |
Boston Scientific | US1011371077 | 5.46 | 104.64 | -1.78% | |
Regeneron Pharma | US75886F1075 | 4.24 | 604.62 | -1.65% | |
Pfizer | US7170811035 | 4.13 | 23.04 | -2.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review